Stated plainly: purity figure · JEEP.
I would like to set this up properly once, rather than adjust it repeatedly.
My budget is real but not tight, and my tolerance for uncertainty is low.
What should I decide now, and what should I defer?
Stated carefully, reading a certificate means checking four things before anything else: traceability to your vial, the test date, the analytical method, and the identity of the testing laboratory.
Writing the lot number on your vial in permanent marker is worth doing because it later proves that the certificate traces to your material.
| Component | Typical share | Counted in purity? | Counted in content? |
|---|---|---|---|
| Target peptide | 88–94 % | Yes, as main peak | Yes |
| Related impurities | 1–3 % | Yes, as other peaks | No |
| Counter-ion (TFA or acetate) | 2–8 % | No | No |
| Residual water | 2–6 % | No | No |
| Bulking agent, if present | 0–40 % | No | No |
The laboratory name and accreditation status can be checked in real time against the testing service's own register, and that two-minute check catches substituted certificates.
Research-grade certificates carry no regulatory backing and no standing in quality systems, and that limitation is worth being explicit about.
One qualification: a single result from a single vial at a single time is a point estimate with no error bar, and no amount of decimal places changes that.
If the certificate does not trace to your vial, it is not evidence about your vial.
edited 24 Jan 2025 by vialroom — updated for the 2026 guidance change
Aggregated, published test results and vendor ratings built from submitted batches. Methodology stated, dataset browsable, no listing fees.
Browse resultsMechanically, a certificate without a method section is giving you a claim rather than a measurement, and claims are not evidence.
The field you have least reason to trust is the one that looks most impressive, because appearance and accuracy are not correlated.
A purity figure to two decimal places with no supporting chromatogram is giving false precision and is a red flag on the same level as spelling errors.
The standards that exist in this space — ICH Q3A, Q3B and various pharmacopoeial chapters — are worth reading once even if nothing you test is obliged to meet them.
The limitation is cost — truly rigorous testing on every lot is expensive enough that most people do not do it, which is exactly why the variation matters.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
On the detail: start from what the certificate claims to measure and what the claimed measurement actually answers, because those are two different questions.
Comparison across certificates from different laboratories is almost never valid, even when the material is the same, because the methods are almost never the same.
The test date matters because a certificate six months older than the vial is not evidence about your material, it is evidence about what the material was like half a year ago.
The caveat is that a certificate is not a guarantee, it is a data point, and treating it as anything else is asking for disappointment.
My working rule is that a document without a lot number, a method section and a test date is marketing.
What a useful certificate carries is debatable, but there are certain fields that almost no research-grade certificate includes despite their being standard in pharmaceutical work.
A method section that differs markedly from pharmacopoeial standards is either innovative or nonstandard, and distinguishing the two requires expertise.
Industry guidance on this topic is consistent because it comes from first principles rather than convention.
Be careful not to over-read this — a certificate that is imperfect is not worthless, it is just a starting point for thought rather than an endpoint.
If the certificate does not trace to your vial, it is not evidence about your vial.
Most certificates are written to look impressive rather than to be informative, and it is worth being sceptical of that gap.
Multiple testing on the same lot reported in a single document suggests internal quality control; identical figures across different lots suggests the same certificate reused.
Published inter-laboratory comparisons of the same material routinely find spreads of half a per cent to a full per cent, which sets realistic expectations.
Worth noting that none of this is medical advice, and a compound sold for research use carries no regulatory approval in any jurisdiction.
The practical summary: check the lot number, ask for the method, and reserve judgement until you have both.
Ask PeptideStack is a static archive. Posting is closed, but the norms are worth stating: answer the question that was asked, show your working, cite the trial or the certificate, and say plainly where the evidence runs out.